APO Research
Talk to an analyst

APO RESEARCH · REPORT

L-(+)-Ergothioneine

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Its molecular structure contains a trimethylated histidine backbone and a sulfur substituted imidazole ring, forming an amino acid betaine with a permanent zwitterionic character. The molecule exists in equilibrium between thiol and thione tautomers. At physiological pH the thione form predominates, which substantially limits spontaneous oxidation and gives ergothioneine greater chemical stability than many conventional low molecular weight thiols. This thione chemistry also permits redox reactions and transition metal coordination while retaining high aqueous solubility. High purity commercial material is typically supplied as a white crystalline powder. The synthetic material assessed by the European Food Safety Authority specifies chemical purity of at least 99.5 percent by HPLC and positive optical rotation consistent with the naturally occurring L configuration.

Natural ergothioneine biosynthesis occurs in selected fungi and bacteria through histidine derived sulfur incorporation pathways. Mushrooms contain particularly high concentrations, while lower concentrations occur in beans, cereals, animal tissues and other foods through biological uptake and food chain transfer. Humans do not possess a known endogenous biosynthetic pathway for ergothioneine and obtain it from dietary sources. Absorption and tissue retention are strongly associated with the SLC22A4 transporter, commonly termed OCTN1 or the ergothioneine transporter, which mediates intestinal uptake, cellular accumulation and renal reabsorption. Ergothioneine can consequently accumulate in erythrocytes and several tissues despite relatively low dietary concentrations. Its thione dominated chemistry gives the molecule resistance to autoxidation and enables reactions with reactive oxygen and nitrogen species and coordination with selected metal ions. These physicochemical properties underpin its use as a functional ingredient, while its precise physiological roles in humans remain an active area of biochemical research.

Industrial L (+) Ergothioneine is manufactured principally by microbial fermentation, enzyme catalyzed synthesis and chemical synthesis. Commercial fermentation routes use engineered microorganisms carrying ergothioneine biosynthetic enzymes, with current FDA GRAS records documenting production using engineered Escherichia coli strains. Chemical production has also been established commercially and was the manufacturing basis of the synthetic material evaluated by EFSA. Enzyme catalyzed routes convert histidine derived precursors through selective sulfur incorporation reactions and are currently used by commercial ingredient manufacturers. These technologies produce chemically equivalent L ergothioneine when stereochemical configuration, molecular identity, purity and impurity specifications are controlled. Commercial material is used in dietary supplements, foods and beverages, cosmetics and personal care formulations, with food use subject to jurisdiction specific regulatory requirements. The European Union currently lists L ergothioneine as an authorised novel food for specified food categories and food supplements.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For L-(+)-Ergothioneine, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable l-(+)-ergothioneine performance?

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Outlook & Growth Opportunities

Global L-(+)-Ergothioneine Market Outlook and Growth Opportunities 2026

6 September 2026208 pages

Choose your research edition.

Industry ResearchL-(+)-Ergothioneine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal L-(+)-Ergothioneine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal L-(+)-Ergothioneine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal L-(+)-Ergothioneine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal L-(+)-Ergothioneine Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, Inc, the global L (+) Ergothioneine market was valued at USD 68.53 million in 2025 and is expected to reach USD 84.17 million in 2026 and USD 191.86 million by 2032, representing a CAGR of 14.72% from 2026 to 2032. Global sales volume is estimated at 25.86 t in 2025 and 33.40 t in 2026, reaching 107.79 t in 2032, equivalent to a volume CAGR of 21.56%. The weighted ex factory net price is estimated at USD 2,650.00 per kg in 2025, USD 2,520.00 per kg in 2026 and USD 1,780.00 per kg in 2032, corresponding to an average annual price decline of 5.63% during 2026 to 2032. Effective manufacturing capacity is estimated at 72.50 t in 2025, 92.01 t in 2026 and 189.97 t in 2032, while utilization increases from 35.67% to 36.30% and 56.74%, respectively. The value expansion therefore comes primarily from higher physical consumption, rising utilization and broader downstream formulation volumes as fermentation productivity and purification economics reduce unit cost.

China is expected to contribute the largest manufacturing increment through GeneIII Biotechnology, Chuanning Biotechnology, Shanghai EGT Synbio, Readline Biotech, SIYOMICRO, Bloomage Biotech, Abiochem and other commercial producers. GeneIII reports monthly L (+) Ergothioneine capacity of 3.00 to 5.00 t, equivalent to 36.00 to 60.00 t on an annualized basis, with product purity reaching 99.99%. This disclosed capacity alone exceeds the audited 2026 global sales volume of 33.40 t and provides a direct physical explanation for the relatively low industry utilization rate. SIYOMICRO has reported stable production scale up in a 100.00 t fermenter, while Readline has commissioned two hundred tonne class shared active ingredient production lines in Zhuhai with commercial scale production of ergothioneine. Chuanning exceeded its 11.00 g/L fermentation titer objective and annual production target in 2025. Bloomage commercially produces MitoEGT through one step biosynthesis, and Shanghai EGT Synbio has established commercial biological production of Dr.Ergo. The current FDA GRAS inventory contains four ergothioneine notices. Blue California, Shanghai EGT Synbio and GeneIII have received FDA no questions letters. Abiochem remains under review.

Fermentation is expected to account for the largest incremental production volume through 2032 as strain productivity, fermentation titer, reactor scale, downstream recovery and crystallization yield improve. Enzymatic synthesis and chemical synthesis remain relevant for selected manufacturing configurations and purity specifications. Dietary supplements are expected to remain the largest application by value, followed by food and beverages and cosmetics and personal care, with pet nutrition representing a smaller commercial application. Regulatory inclusion levels provide a useful physical demand anchor. The European Union permits up to 30.00 mg per day in food supplements for the general population, 25.00 mg per kg in alcohol free beverages and milk based drinks, 40.00 mg per kg in fresh milk products, 200.00 mg per kg in cereal bars and 250.00 mg per kg in chocolate confectionery. At 30.00 mg per day, 1.00 t of L (+) Ergothioneine corresponds to approximately 33.33 million supplement consumption days. At 25.00 mg per kg, 1.00 t can theoretically supply 40,000.00 t of beverage at the permitted maximum inclusion level. These low unit dosages allow large downstream finished product volumes to absorb relatively modest ingredient tonnage, while continued price reductions materially enlarge the addressable formulation base. Commercial demand is recurrent because L (+) Ergothioneine is consumed within finished formulations and replenished with continuing supplement, food, beverage, cosmetic and pet nutrition production.

Read the full market overview

This report provides an overview of the global L-(+)-Ergothioneine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of L-(+)-Ergothioneine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents L-(+)-Ergothioneine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the L-(+)-Ergothioneine market size, projected growth trends, production technologies, key applications, and end-use industries.

L-(+)-Ergothioneine Segment by Company

Bloomage Biotech

Chuanning Biotechnology

Shanghai EGT Synbio

GeneIII Biotechnology

Readline Biotech

SIYOMICRO

Abiochem

Magic Health

Seedling Bio

Focusfreda

Nutri Force

Natural Field

GsynBio

Hechen Bioworkx

Changzhou Kaixing Biotechnology

Spec Chem Industry

Conagen

Mironova Labs

NAGASE

L-(+)-Ergothioneine Segment by Type

Fermentation

Enzymatic Synthesis

Chemical Synthesis

L-(+)-Ergothioneine Segment by Application

Dietary Supplements

Food & Beverages

Cosmetics & Personal Care

Pet Nutrition

L-(+)-Ergothioneine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global L-(+)-Ergothioneine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions L-(+)-Ergothioneine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify L-(+)-Ergothioneine significant trends, drivers, influence factors in global and regions.

6. To analyze L-(+)-Ergothioneine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global L-(+)-Ergothioneine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of L-(+)-Ergothioneine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of L-(+)-Ergothioneine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the L-(+)-Ergothioneine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global L-(+)-Ergothioneine industry.

Chapter 3: Detailed analysis of L-(+)-Ergothioneine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of L-(+)-Ergothioneine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of L-(+)-Ergothioneine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. L-(+)-Ergothioneine Industry Trends Table 2. L-(+)-Ergothioneine Industry Drivers Table 3. L-(+)-Ergothioneine Industry Opportunities and Challenges Table 4. L-(+)-Ergothioneine Industry Restraints Table 5. Global L-(+)-Ergothioneine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global L-(+)-Ergothioneine Revenue Share by Company (2021-2026) Table 7. Global L-(+)-Ergothioneine Sales Volume by Company (kg) & (2021-2026) Table 8. Global L-(+)-Ergothioneine Sales Volume Share by Company (2021-2026) Table 9. Global L-(+)-Ergothioneine Average Price (USD/kg) of Company (2021-2026) Table 10. Global L-(+)-Ergothioneine Company Ranking, (2024-2026) & (USD Million) Table 11. Global L-(+)-Ergothioneine Key Company Manufacturing Base & Headquarters Table 12. Global L-(+)-Ergothioneine Company, Product Type & Application Table 13. Global L-(+)-Ergothioneine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global L-(+)-Ergothioneine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fermentation Table 18. Significant Companies of Enzymatic Synthesis Table 19. Significant Companies of Chemical Synthesis Table 20. Global L-(+)-Ergothioneine Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global L-(+)-Ergothioneine Sales Volume by Type (2021-2026) & (kg) Table 22. Global L-(+)-Ergothioneine Sales Volume by Type (2027-2032) & (kg) Table 23. Global L-(+)-Ergothioneine Sales Volume Share by Type (2021-2026) Table 24. Global L-(+)-Ergothioneine Sales Volume Share by Type (2027-2032) Table 25. Global L-(+)-Ergothioneine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global L-(+)-Ergothioneine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global L-(+)-Ergothioneine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global L-(+)-Ergothioneine Sales Value Share by Type (2021-2026) Table 29. Global L-(+)-Ergothioneine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dietary Supplements Table 31. Significant Companies of Food & Beverages Table 32. Significant Companies of Cosmetics & Personal Care Table 33. Significant Companies of Pet Nutrition Table 34. Global L-(+)-Ergothioneine Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 35. Global L-(+)-Ergothioneine Sales Volume by Application (2021-2026) & (kg) Table 36. Global L-(+)-Ergothioneine Sales Volume by Application (2027-2032) & (kg) Table 37. Global L-(+)-Ergothioneine Sales Volume Share by Application (2021-2026) Table 38. Global L-(+)-Ergothioneine Sales Volume Share by Application (2027-2032) Table 39. Global L-(+)-Ergothioneine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global L-(+)-Ergothioneine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global L-(+)-Ergothioneine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global L-(+)-Ergothioneine Sales Value Share by Application (2021-2026) Table 43. Global L-(+)-Ergothioneine Sales Value Share by Application (2027-2032) Table 44. Global L-(+)-Ergothioneine Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 45. Global L-(+)-Ergothioneine Sales by Region (2021-2026) & (kg) Table 46. Global L-(+)-Ergothioneine Sales Market Share by Region (2021-2026) Table 47. Global L-(+)-Ergothioneine Sales by Region (2027-2032) & (kg) Table 48. Global L-(+)-Ergothioneine Sales Market Share by Region (2027-2032) Table 49. Global L-(+)-Ergothioneine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global L-(+)-Ergothioneine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global L-(+)-Ergothioneine Sales Value Share by Region (2021-2026) Table 52. Global L-(+)-Ergothioneine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global L-(+)-Ergothioneine Sales Value Share by Region (2027-2032) Table 54. Global L-(+)-Ergothioneine Market Average Price (USD/kg) by Region (2021-2026) Table 55. Global L-(+)-Ergothioneine Market Average Price (USD/kg) by Region (2027-2032) Table 56. Global L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 57. Global L-(+)-Ergothioneine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 59. Global L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 60. Global L-(+)-Ergothioneine Sales by Country (2027-2032) & (kg) Table 61. Global L-(+)-Ergothioneine Sales Market Share by Country (2027-2032) Table 62. Global L-(+)-Ergothioneine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global L-(+)-Ergothioneine Sales Value Market Share by Country (2021-2026) Table 64. Global L-(+)-Ergothioneine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global L-(+)-Ergothioneine Sales Value Market Share by Country (2027-2032) Table 66. Bloomage Biotech Company Information Table 67. Bloomage Biotech Business Overview Table 68. Bloomage Biotech L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. Bloomage Biotech L-(+)-Ergothioneine Product Portfolio Table 70. Bloomage Biotech Recent Development Table 71. Chuanning Biotechnology Company Information Table 72. Chuanning Biotechnology Business Overview Table 73. Chuanning Biotechnology L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio Table 75. Chuanning Biotechnology Recent Development Table 76. Shanghai EGT Synbio Company Information Table 77. Shanghai EGT Synbio Business Overview Table 78. Shanghai EGT Synbio L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio Table 80. Shanghai EGT Synbio Recent Development Table 81. GeneIII Biotechnology Company Information Table 82. GeneIII Biotechnology Business Overview Table 83. GeneIII Biotechnology L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio Table 85. GeneIII Biotechnology Recent Development Table 86. Readline Biotech Company Information Table 87. Readline Biotech Business Overview Table 88. Readline Biotech L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Readline Biotech L-(+)-Ergothioneine Product Portfolio Table 90. Readline Biotech Recent Development Table 91. SIYOMICRO Company Information Table 92. SIYOMICRO Business Overview Table 93. SIYOMICRO L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. SIYOMICRO L-(+)-Ergothioneine Product Portfolio Table 95. SIYOMICRO Recent Development Table 96. Abiochem Company Information Table 97. Abiochem Business Overview Table 98. Abiochem L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Abiochem L-(+)-Ergothioneine Product Portfolio Table 100. Abiochem Recent Development Table 101. Magic Health Company Information Table 102. Magic Health Business Overview Table 103. Magic Health L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Magic Health L-(+)-Ergothioneine Product Portfolio Table 105. Magic Health Recent Development Table 106. Seedling Bio Company Information Table 107. Seedling Bio Business Overview Table 108. Seedling Bio L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Seedling Bio L-(+)-Ergothioneine Product Portfolio Table 110. Seedling Bio Recent Development Table 111. Focusfreda Company Information Table 112. Focusfreda Business Overview Table 113. Focusfreda L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Focusfreda L-(+)-Ergothioneine Product Portfolio Table 115. Focusfreda Recent Development Table 116. Nutri Force Company Information Table 117. Nutri Force Business Overview Table 118. Nutri Force L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. Nutri Force L-(+)-Ergothioneine Product Portfolio Table 120. Nutri Force Recent Development Table 121. Natural Field Company Information Table 122. Natural Field Business Overview Table 123. Natural Field L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. Natural Field L-(+)-Ergothioneine Product Portfolio Table 125. Natural Field Recent Development Table 126. GsynBio Company Information Table 127. GsynBio Business Overview Table 128. GsynBio L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. GsynBio L-(+)-Ergothioneine Product Portfolio Table 130. GsynBio Recent Development Table 131. Hechen Bioworkx Company Information Table 132. Hechen Bioworkx Business Overview Table 133. Hechen Bioworkx L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio Table 135. Hechen Bioworkx Recent Development Table 136. Changzhou Kaixing Biotechnology Company Information Table 137. Changzhou Kaixing Biotechnology Business Overview Table 138. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 139. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio Table 140. Changzhou Kaixing Biotechnology Recent Development Table 141. Spec Chem Industry Company Information Table 142. Spec Chem Industry Business Overview Table 143. Spec Chem Industry L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 144. Spec Chem Industry L-(+)-Ergothioneine Product Portfolio Table 145. Spec Chem Industry Recent Development Table 146. Conagen Company Information Table 147. Conagen Business Overview Table 148. Conagen L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 149. Conagen L-(+)-Ergothioneine Product Portfolio Table 150. Conagen Recent Development Table 151. Mironova Labs Company Information Table 152. Mironova Labs Business Overview Table 153. Mironova Labs L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 154. Mironova Labs L-(+)-Ergothioneine Product Portfolio Table 155. Mironova Labs Recent Development Table 156. NAGASE Company Information Table 157. NAGASE Business Overview Table 158. NAGASE L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 159. NAGASE L-(+)-Ergothioneine Product Portfolio Table 160. NAGASE Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. L-(+)-Ergothioneine Distributors List Table 164. L-(+)-Ergothioneine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. L-(+)-Ergothioneine Product Image Figure 2. Global L-(+)-Ergothioneine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 4. Global L-(+)-Ergothioneine Sales (2021-2032) & (kg) Figure 5. Global L-(+)-Ergothioneine Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global L-(+)-Ergothioneine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fermentation Image Figure 10. Enzymatic Synthesis Image Figure 11. Chemical Synthesis Image Figure 12. Global L-(+)-Ergothioneine Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global L-(+)-Ergothioneine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global L-(+)-Ergothioneine Sales Volume Share by Type (2021-2032) Figure 15. Global L-(+)-Ergothioneine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global L-(+)-Ergothioneine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global L-(+)-Ergothioneine Sales Value Share by Type (2021-2032) Figure 18. Dietary Supplements Image Figure 19. Food & Beverages Image Figure 20. Cosmetics & Personal Care Image Figure 21. Pet Nutrition Image Figure 22. Global L-(+)-Ergothioneine Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global L-(+)-Ergothioneine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global L-(+)-Ergothioneine Sales Volume Share by Application (2021-2032) Figure 25. Global L-(+)-Ergothioneine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global L-(+)-Ergothioneine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global L-(+)-Ergothioneine Sales Value Share by Application (2021-2032) Figure 28. Global L-(+)-Ergothioneine Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 29. Global L-(+)-Ergothioneine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global L-(+)-Ergothioneine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global L-(+)-Ergothioneine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 33. North America L-(+)-Ergothioneine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe L-(+)-Ergothioneine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific L-(+)-Ergothioneine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 39. South America L-(+)-Ergothioneine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa L-(+)-Ergothioneine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa L-(+)-Ergothioneine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. L-(+)-Ergothioneine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. L-(+)-Ergothioneine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Fermentation
  • Enzymatic Synthesis
  • Chemical Synthesis
Applications
  • Dietary Supplements
  • Food & Beverages
  • Cosmetics & Personal Care
  • Pet Nutrition
Companies covered
  • Bloomage Biotech
  • Chuanning Biotechnology
  • Shanghai EGT Synbio
  • GeneIII Biotechnology
  • Readline Biotech
  • SIYOMICRO
  • Abiochem
  • Magic Health
  • Seedling Bio
  • Focusfreda
  • Nutri Force
  • Natural Field
  • GsynBio
  • Hechen Bioworkx
  • Changzhou Kaixing Biotechnology
  • Spec Chem Industry
  • Conagen
  • Mironova Labs
  • NAGASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global L-(+)-Ergothioneine Sales Value (2021-2032)
  4. 1.2.2 Global L-(+)-Ergothioneine Sales Volume (2021-2032)
  5. 1.2.3 Global L-(+)-Ergothioneine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 L-(+)-Ergothioneine Market Dynamics
  1. 2.1 L-(+)-Ergothioneine Industry Trends
  2. 2.2 L-(+)-Ergothioneine Industry Drivers
  3. 2.3 L-(+)-Ergothioneine Industry Opportunities and Challenges
  4. 2.4 L-(+)-Ergothioneine Industry Restraints
3 L-(+)-Ergothioneine Market by Company
  1. 3.1 Global L-(+)-Ergothioneine Company Revenue Ranking in 2025
  2. 3.2 Global L-(+)-Ergothioneine Revenue by Company (2021-2026)
  3. 3.3 Global L-(+)-Ergothioneine Sales Volume by Company (2021-2026)
  4. 3.4 Global L-(+)-Ergothioneine Average Price by Company (2021-2026)
  5. 3.5 Global L-(+)-Ergothioneine Company Ranking (2024-2026)
  6. 3.6 Global L-(+)-Ergothioneine Company Manufacturing Base and Headquarters
  7. 3.7 Global L-(+)-Ergothioneine Company Product Type and Application
  8. 3.8 Global L-(+)-Ergothioneine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global L-(+)-Ergothioneine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 L-(+)-Ergothioneine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 L-(+)-Ergothioneine Market by Type
  1. 4.1 L-(+)-Ergothioneine Type Introduction
  2. 4.1.1 Fermentation
  3. 4.1.2 Enzymatic Synthesis
  4. 4.1.3 Chemical Synthesis
  5. 4.2 Global L-(+)-Ergothioneine Sales Volume by Type
  6. 4.2.1 Global L-(+)-Ergothioneine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global L-(+)-Ergothioneine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global L-(+)-Ergothioneine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global L-(+)-Ergothioneine Sales Value by Type
  10. 4.3.1 Global L-(+)-Ergothioneine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global L-(+)-Ergothioneine Sales Value by Type (2021-2032)
  12. 4.3.3 Global L-(+)-Ergothioneine Sales Value Share by Type (2021-2032)
5 L-(+)-Ergothioneine Market by Application
  1. 5.1 L-(+)-Ergothioneine Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Food & Beverages
  4. 5.1.3 Cosmetics & Personal Care
  5. 5.1.4 Pet Nutrition
  6. 5.2 Global L-(+)-Ergothioneine Sales Volume by Application
  7. 5.2.1 Global L-(+)-Ergothioneine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global L-(+)-Ergothioneine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global L-(+)-Ergothioneine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global L-(+)-Ergothioneine Sales Value by Application
  11. 5.3.1 Global L-(+)-Ergothioneine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global L-(+)-Ergothioneine Sales Value by Application (2021-2032)
  13. 5.3.3 Global L-(+)-Ergothioneine Sales Value Share by Application (2021-2032)
6 L-(+)-Ergothioneine Regional Sales and Value Analysis
  1. 6.1 Global L-(+)-Ergothioneine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global L-(+)-Ergothioneine Sales by Region (2021-2032)
  3. 6.2.1 Global L-(+)-Ergothioneine Sales by Region: 2021-2026
  4. 6.2.2 Global L-(+)-Ergothioneine Sales by Region (2027-2032)
  5. 6.3 Global L-(+)-Ergothioneine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global L-(+)-Ergothioneine Sales Value by Region (2021-2032)
  7. 6.4.1 Global L-(+)-Ergothioneine Sales Value by Region: 2021-2026
  8. 6.4.2 Global L-(+)-Ergothioneine Sales Value by Region (2027-2032)
  9. 6.5 Global L-(+)-Ergothioneine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America L-(+)-Ergothioneine Sales Value (2021-2032)
  12. 6.6.2 North America L-(+)-Ergothioneine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe L-(+)-Ergothioneine Sales Value (2021-2032)
  15. 6.7.2 Europe L-(+)-Ergothioneine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific L-(+)-Ergothioneine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific L-(+)-Ergothioneine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America L-(+)-Ergothioneine Sales Value (2021-2032)
  21. 6.9.2 South America L-(+)-Ergothioneine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa L-(+)-Ergothioneine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa L-(+)-Ergothioneine Sales Value Share by Country, 2025 VS 2032
7 L-(+)-Ergothioneine Country-level Sales and Value Analysis
  1. 7.1 Global L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global L-(+)-Ergothioneine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global L-(+)-Ergothioneine Sales by Country (2021-2032)
  4. 7.3.1 Global L-(+)-Ergothioneine Sales by Country (2021-2026)
  5. 7.3.2 Global L-(+)-Ergothioneine Sales by Country (2027-2032)
  6. 7.4 Global L-(+)-Ergothioneine Sales Value by Country (2021-2032)
  7. 7.4.1 Global L-(+)-Ergothioneine Sales Value by Country (2021-2026)
  8. 7.4.2 Global L-(+)-Ergothioneine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt L-(+)-Ergothioneine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt L-(+)-Ergothioneine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt L-(+)-Ergothioneine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bloomage Biotech
  2. 8.1.1 Bloomage Biotech Company Information
  3. 8.1.2 Bloomage Biotech Business Overview
  4. 8.1.3 Bloomage Biotech L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bloomage Biotech L-(+)-Ergothioneine Product Portfolio
  6. 8.1.5 Bloomage Biotech Recent Developments
  7. 8.2 Chuanning Biotechnology
  8. 8.2.1 Chuanning Biotechnology Company Information
  9. 8.2.2 Chuanning Biotechnology Business Overview
  10. 8.2.3 Chuanning Biotechnology L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio
  12. 8.2.5 Chuanning Biotechnology Recent Developments
  13. 8.3 Shanghai EGT Synbio
  14. 8.3.1 Shanghai EGT Synbio Company Information
  15. 8.3.2 Shanghai EGT Synbio Business Overview
  16. 8.3.3 Shanghai EGT Synbio L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio
  18. 8.3.5 Shanghai EGT Synbio Recent Developments
  19. 8.4 GeneIII Biotechnology
  20. 8.4.1 GeneIII Biotechnology Company Information
  21. 8.4.2 GeneIII Biotechnology Business Overview
  22. 8.4.3 GeneIII Biotechnology L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio
  24. 8.4.5 GeneIII Biotechnology Recent Developments
  25. 8.5 Readline Biotech
  26. 8.5.1 Readline Biotech Company Information
  27. 8.5.2 Readline Biotech Business Overview
  28. 8.5.3 Readline Biotech L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Readline Biotech L-(+)-Ergothioneine Product Portfolio
  30. 8.5.5 Readline Biotech Recent Developments
  31. 8.6 SIYOMICRO
  32. 8.6.1 SIYOMICRO Company Information
  33. 8.6.2 SIYOMICRO Business Overview
  34. 8.6.3 SIYOMICRO L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SIYOMICRO L-(+)-Ergothioneine Product Portfolio
  36. 8.6.5 SIYOMICRO Recent Developments
  37. 8.7 Abiochem
  38. 8.7.1 Abiochem Company Information
  39. 8.7.2 Abiochem Business Overview
  40. 8.7.3 Abiochem L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abiochem L-(+)-Ergothioneine Product Portfolio
  42. 8.7.5 Abiochem Recent Developments
  43. 8.8 Magic Health
  44. 8.8.1 Magic Health Company Information
  45. 8.8.2 Magic Health Business Overview
  46. 8.8.3 Magic Health L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Magic Health L-(+)-Ergothioneine Product Portfolio
  48. 8.8.5 Magic Health Recent Developments
  49. 8.9 Seedling Bio
  50. 8.9.1 Seedling Bio Company Information
  51. 8.9.2 Seedling Bio Business Overview
  52. 8.9.3 Seedling Bio L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Seedling Bio L-(+)-Ergothioneine Product Portfolio
  54. 8.9.5 Seedling Bio Recent Developments
  55. 8.10 Focusfreda
  56. 8.10.1 Focusfreda Company Information
  57. 8.10.2 Focusfreda Business Overview
  58. 8.10.3 Focusfreda L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Focusfreda L-(+)-Ergothioneine Product Portfolio
  60. 8.10.5 Focusfreda Recent Developments
  61. 8.11 Nutri Force
  62. 8.11.1 Nutri Force Company Information
  63. 8.11.2 Nutri Force Business Overview
  64. 8.11.3 Nutri Force L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nutri Force L-(+)-Ergothioneine Product Portfolio
  66. 8.11.5 Nutri Force Recent Developments
  67. 8.12 Natural Field
  68. 8.12.1 Natural Field Company Information
  69. 8.12.2 Natural Field Business Overview
  70. 8.12.3 Natural Field L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Natural Field L-(+)-Ergothioneine Product Portfolio
  72. 8.12.5 Natural Field Recent Developments
  73. 8.13 GsynBio
  74. 8.13.1 GsynBio Company Information
  75. 8.13.2 GsynBio Business Overview
  76. 8.13.3 GsynBio L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 GsynBio L-(+)-Ergothioneine Product Portfolio
  78. 8.13.5 GsynBio Recent Developments
  79. 8.14 Hechen Bioworkx
  80. 8.14.1 Hechen Bioworkx Company Information
  81. 8.14.2 Hechen Bioworkx Business Overview
  82. 8.14.3 Hechen Bioworkx L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio
  84. 8.14.5 Hechen Bioworkx Recent Developments
  85. 8.15 Changzhou Kaixing Biotechnology
  86. 8.15.1 Changzhou Kaixing Biotechnology Company Information
  87. 8.15.2 Changzhou Kaixing Biotechnology Business Overview
  88. 8.15.3 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio
  90. 8.15.5 Changzhou Kaixing Biotechnology Recent Developments
  91. 8.16 Spec Chem Industry
  92. 8.16.1 Spec Chem Industry Company Information
  93. 8.16.2 Spec Chem Industry Business Overview
  94. 8.16.3 Spec Chem Industry L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Spec Chem Industry L-(+)-Ergothioneine Product Portfolio
  96. 8.16.5 Spec Chem Industry Recent Developments
  97. 8.17 Conagen
  98. 8.17.1 Conagen Company Information
  99. 8.17.2 Conagen Business Overview
  100. 8.17.3 Conagen L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Conagen L-(+)-Ergothioneine Product Portfolio
  102. 8.17.5 Conagen Recent Developments
  103. 8.18 Mironova Labs
  104. 8.18.1 Mironova Labs Company Information
  105. 8.18.2 Mironova Labs Business Overview
  106. 8.18.3 Mironova Labs L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Mironova Labs L-(+)-Ergothioneine Product Portfolio
  108. 8.18.5 Mironova Labs Recent Developments
  109. 8.19 NAGASE
  110. 8.19.1 NAGASE Company Information
  111. 8.19.2 NAGASE Business Overview
  112. 8.19.3 NAGASE L-(+)-Ergothioneine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 NAGASE L-(+)-Ergothioneine Product Portfolio
  114. 8.19.5 NAGASE Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 L-(+)-Ergothioneine Value Chain Analysis
  2. 9.1.1 L-(+)-Ergothioneine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 L-(+)-Ergothioneine Sales Mode & Process
  6. 9.2 L-(+)-Ergothioneine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 L-(+)-Ergothioneine Distributors
  9. 9.2.3 L-(+)-Ergothioneine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst